We're investing over £280,000 to accelerate the development of new Parkinson's drugs
Date
News
Date
Light therapy as a potential treatment for Parkinson's hits the headlines. We take a deeper look at what we know about it so far.
Date
Parkinson's UK campaigners handed in over 1,200 signed postcards to the Department of Health and Social Care, calling for investment in training on Parkinson's-related dementia for social care staff.
Date
Back in the summer, we called upon the Parkinson's community to take part in 5 clinical trials that were at a potential risk of closing. Thanks to you, we had an incredible response and want to keep up the momentum of encouraging people to take part in research.
Date
The biotech company NRG Therapeutics has received a large investment to continue its drug development project into life-changing new treatments.
Date
An international clinical trial looking at using stem cells to treat Parkinson's has been granted approval to go ahead initially in Sweden.
Date
The 2022 Parkinson's UK AGM took place on Saturday 15 October with members hearing about the last year at the charity.
Date
We're investing £2m in Enterin's phase 2 clinical trial of its drug ENT-01, a potential treatment for Parkinson's dementia.
Date
Over the last 2 years, Vivifi Biotech has made progress towards a trial that aims to overcome the challenges of the last trial. Now, it's starting work on the final phase of planning.
Date
An update on who we met at the Labour and Conservative party conferences